Smart pH-responsive nanomedicines for disease therapyJongyoon Shinn, Yonghyun Lee, Nuri Kwon et al.|Journal of Pharmaceutical Investigation|2022Cited by 108
Antioxidative Hyaluronic Acid–Bilirubin Nanomedicine Targeting Activated Hepatic Stellate Cells for Anti-Hepatic-Fibrosis TherapyJongyoon Shinn, Yonghyun Lee, Seojeong Kim et al.|ACS Nano|2024Cited by 86
Hyaluronic acid-bilirubin nanomedicine-based combination chemoimmunotherapyYonghyun Lee, James J. Moon, Nouri Neamati et al.|Nature Communications|2023Cited by 84
Recent progress in development and applications of second near‐infrared (NIR-II) nanoprobesJongyoon Shinn, Yonghyun Lee, Hyon Kyong Lee et al.|Archives of Pharmacal Research|2021Cited by 38
Oral Nanomedicines for siRNA Delivery to Treat Inflammatory Bowel DiseaseJongyoon Shinn, Yonghyun Lee, Joohyeon Kim et al.|Pharmaceutics|2022Cited by 20